e-Therapeutics Starts Phase IIb Trial of ETS6103 in Major Depressive Disorder

News   Oct 31, 2013

 
e-Therapeutics Starts Phase IIb Trial of ETS6103 in Major Depressive Disorder
 
 
 
FURTHER INFORMATION
 

This content appears on:

Drug Discovery

To personalize the content you see on Technology Networks, Log In or Join Today

Login Join
 
 

Comments | 0 ADD COMMENT